Compare Organo Corp. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROCE of 17.33%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 96.69
3
Healthy long term growth as Net Sales has grown by an annual rate of 11.09% and Operating profit at 25.92%
4
Flat results in Dec 25
5
With ROCE of 24.55%, it has a very attractive valuation with a 2.82 Enterprise value to Capital Employed
6
Market Beating performance in long term as well as near term
Stock DNA
Industrial Manufacturing
JPY 766,326 Million (Mid Cap)
15.00
NA
0.00%
0.03
21.48%
5.96
Revenue and Profits:
Net Sales:
44,936 Million
(Quarterly Results - Dec 2025)
Net Profit:
6,471 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
19.45%
0%
19.45%
6 Months
40.62%
0%
40.62%
1 Year
115.72%
0%
115.72%
2 Years
90.31%
0%
90.31%
3 Years
358.88%
0%
358.88%
4 Years
88.23%
0%
88.23%
5 Years
145.41%
0%
145.41%
Organo Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.09%
EBIT Growth (5y)
25.92%
EBIT to Interest (avg)
96.69
Debt to EBITDA (avg)
0.46
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
1.12
Tax Ratio
25.25%
Dividend Payout Ratio
30.45%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.33%
ROE (avg)
14.66%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
2.91
EV to EBIT
11.48
EV to EBITDA
10.81
EV to Capital Employed
2.82
EV to Sales
2.19
PEG Ratio
0.37
Dividend Yield
0.01%
ROCE (Latest)
24.55%
ROE (Latest)
20.00%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
44,936.00
41,375.00
8.61%
Operating Profit (PBDIT) excl Other Income
9,244.00
8,737.00
5.80%
Interest
67.00
57.00
17.54%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6,471.00
5,839.00
10.82%
Operating Profit Margin (Excl OI)
194.40%
199.80%
-0.54%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 8.61% vs 1.49% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 10.82% vs 23.60% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
163,269.00
150,356.00
8.59%
Operating Profit (PBDIT) excl Other Income
33,046.00
24,555.00
34.58%
Interest
246.00
240.00
2.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
24,186.00
17,334.00
39.53%
Operating Profit Margin (Excl OI)
190.60%
149.90%
4.07%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 8.59% vs 13.54% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 39.53% vs 47.35% in Mar 2024
About Organo Corp. 
Organo Corp.
Industrial Manufacturing
No Details Available.
Company Coordinates 
No Company Details Available






